Imaging in primary penile cancer: current status and future directions

被引:0
|
作者
Rohit Kochhar
Ben Taylor
Vijay Sangar
机构
[1] The Christie,Department of Radiology
[2] NHS Foundation Trust,Department of Urology
[3] The Christie,undefined
[4] NHS Foundation Trust,undefined
来源
European Radiology | 2010年 / 20卷
关键词
Penile cancer; Magnetic resonance imaging; Computed tomography; Ultrasound; Sentinel lymph node;
D O I
暂无
中图分类号
学科分类号
摘要
Penile cancer is a rare neoplasm in the developed world. Clinical assessment often results in inaccurate staging and radiological techniques have a key role in staging and postoperative assessment. Magnetic resonance imaging (MRI) depicts penile anatomy in detail and is the most accurate technique for local staging and postoperative follow-up. MRI and ultrasound (US), although helpful for assessment of lymph nodes, are not reliable enough for accurate nodal staging. US-guided fine needle aspiration cytology (FNAC), however, remains a valuable tool to confirm metastases in suspicious inguinal nodes. Lymphoscintigraphy with dynamic sentinel node biopsy (DSNB) is a promising technique used to predict occult lymph node metastases. Novel imaging techniques such as positron emission tomography/computed tomography (PET-CT) and nanoparticle enhanced MRI have high sensitivity and specificity for lymph node metastases but their availability is limited and clinical utility is not fully established. The radiologist needs to be familiar with the normal penile anatomy, imaging appearances of pre- and post-treatment penile cancer, and the advantages and limitations of the available imaging techniques. This review highlights the above points and presents a systematic approach to make the best use of imaging in the management of patients with penile cancer.
引用
收藏
页码:36 / 47
页数:11
相关论文
共 50 条
  • [31] Management of pancreatic cancer: Current status and future directions
    H. Ramesh
    Indian Journal of Surgery, 2009, 71 : 368 - 372
  • [33] Immunotherapy in breast cancer: Current status and future directions
    Basu, Amrita
    Ramamoorthi, Ganesan
    Jia, Yongsheng
    Faughn, Jon
    Wiener, Doris
    Awshah, Sabrina
    Kodumudi, Krithika
    Czerniecki, Brian J.
    IMMUNOTHERAPY OF CANCER, 2019, 143 : 295 - 349
  • [34] Management of Pancreatic Cancer: Current Status and Future Directions
    Ramesh, H.
    INDIAN JOURNAL OF SURGERY, 2010, 72 (04) : 285 - 289
  • [35] Breast cancer chemoprevention: Current status and future directions
    Wickerham, DL
    Tan-Chiu, E
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 253 - 259
  • [36] Lung cancer chemoprevention: current status and future directions
    Mao, Jenny T.
    Durvasula, Ravi
    CURRENT PULMONOLOGY REPORTS, 2012, 1 (01) : 9 - 20
  • [37] Current Status and Future Directions in the Management of Pancreatic Cancer
    Chandrakanth Are
    Asish Patel
    Indian Journal of Surgical Oncology, 2015, 6 (1) : 3 - 5
  • [38] Breast Cancer Radiogenomics: Current Status and Future Directions
    Grimm, Lars J.
    Mazurowski, Maciej A.
    ACADEMIC RADIOLOGY, 2020, 27 (01) : 39 - 46
  • [39] Prostate Cancer Registries: Current Status and Future Directions
    Gandaglia, Giorgio
    Bray, Freddie
    Cooperberg, Matthew R.
    Karnes, R. Jeffrey
    Leveridge, Michael J.
    Moretti, Kim
    Murphy, Declan G.
    Penson, David F.
    Miller, David C.
    EUROPEAN UROLOGY, 2016, 69 (06) : 998 - 1012
  • [40] Epothilones in breast cancer: current status and future directions
    Atzori, Francesco
    Fornier, Monica
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1299 - 1311